Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Valeant Pharmaceuticals International Inc

+ Add to Watchlist

VRX:CN

203.1700 CAD 0.4600 0.23%

As of 16:00:00 ET on 01/30/2015.

Company Profile for Valeant Pharmaceuticals International Inc (VRX)

Valeant Pharmaceuticals International, Inc. develops and distributes drugs. The Company develops drugs for unmet medical needs in central nervous system disorders, and distributes generic and branded generic drugs in Latin America and Eastern Europe.

Contact Information

Valeant Pharmaceuticals International Inc

700 Route 202/206
Bridgewater, NJ 08807
United States
Phone: 1-908-927-1400
Fax: 1-908-927-1401

Key Executives for Valeant Pharmaceuticals International Inc (VRX)

Laizer D KornwasserChairman/Exec VPJ Michael Pearson "Mike"Chief Executive Officer
Pavel MirovskyPresident/Gen Mgr:EuropeHoward B SchillerExec VP/CFO
Robert R Chai-OnnExec VP/Chief Legal Ofcr/SecyBrian M StolzExec VP:Administration
Laurie W LittleVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil